Trump’s Tariff Tactic: Small Start, 250% Ambition for Medicines
Trump outlines a plan for tariffs on foreign-made pharmaceuticals, starting small and potentially reaching 250% in the near future.
Pharma
Read More
Trump’s Pharma Tariff Threat: Experts Question the Benefits
Experts doubt Trump’s pharma tariffs will lower drug prices or boost security, citing the challenges of a global supply chain and high U.S. production costs.
Chinese Chamber Pushes Back Against U.S. Trade Bullying
The China Chamber of Commerce opposes U.S. trade bullying, supporting countermeasures to protect global healthcare rights.
AstraZeneca CEO Praises Unique Support from Chinese Government
AstraZeneca CEO Pascal Soriot praises the unique support from the Chinese government, noting a partnership that boosts public health and economic growth.
Mohammed Tawil Drives Pharma Innovation in the Chinese Mainland
Mohammed Tawil leads Boehringer Ingelheim’s operations in the Chinese mainland, aiming for groundbreaking treatments and a global talent drive by 2030.